论文信息 - 1299O_PRPrimary results from the phase III ALUR study of alectinib versus chemotherapy in previously treated ALK+ non-small-cell lung cancer (NSCLC) - 字舞流文

1299O_PRPrimary results from the phase III ALUR study of alectinib versus chemotherapy in previously treated ALK+ non-small-cell lung cancer (NSCLC)

S. Novello | R. Dziadziuszko | J. Mazières | J. Wolf | A. Cardona | Å. Helland | H. Johannsdottir | F. Griesinger | J. Castro | B. Balas | I. Oh | M. Migliorino | A. Kotb | A. Zeiter | A. Das-Gupta